Target intelligence / Profile preview

RNA, U6 small nuclear 199, pseudogene (RNU6-199P)

Target
RNU6-199P
Molecular classification
Other, Processed pseudogene derived from small nuclear RNA (snRNA)
01

Overview

RNU6-199P is a processed pseudogene of the U6 small nuclear RNA. U6 snRNA is a highly conserved noncoding RNA essential for spliceosome function, catalyzing pre-mRNA splicing in the nucleus[1][3]. However, RNU6-199P itself is a transcriptionally inactive genomic copy, typically formed by retrotransposition—specifically LINE-1 elements copying U6 snRNA into new locations in the genome[2]. These pseudogenes generally do not encode functional RNA or protein and serve as markers of retrotransposition history rather than having a biological or therapeutic role. Their presence may help researchers study genome evolution and retrotransposon activity but does not imply function in gene regulation, disease, or as a drug target[2][3]. If you are seeking data on the functional U6 small nuclear RNA, refer to "U6 small nuclear RNA" or "U6 snRNA" instead of this pseudogene designation[1][3]. If you need actual drug targets, the U6 pseudogene family is not included.

Other names
RNU6-199PU6 small nuclear RNA 199 pseudogene
02

Mechanism of action

None

03

Biological functions

None
04

Disease associations

None specific
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on RNA, U6 small nuclear 199, pseudogene (RNU6-199P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 199, pseudogene (RNU6-199P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call